Order Article Reprints

Brstilo L, Reyes Valenzuela G, Caraballo R, Pérez Montilla C, García Bournissen F, Cáceres Guido P, Schaiquevich P. Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies. Pharmaceutics. 2023; 15(8):2120. https://doi.org/10.3390/pharmaceutics15082120

Brstilo, Lucas, Gabriela Reyes Valenzuela, Roberto Caraballo, Carlos Pérez Montilla, Facundo García Bournissen, Paulo Cáceres Guido, and Paula Schaiquevich. 2023. "Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies" Pharmaceutics 15, no. 8: 2120. https://doi.org/10.3390/pharmaceutics15082120

Brstilo, L., Reyes Valenzuela, G., Caraballo, R., Pérez Montilla, C., García Bournissen, F., Cáceres Guido, P., & Schaiquevich, P. (2023). Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies. Pharmaceutics, 15(8), 2120. https://doi.org/10.3390/pharmaceutics15082120